Aijaz Ahmed - Concepedia

Author

Aijaz Ahmed

Also Known As

A Ahmed, A H M Tanvir Ahmed, A. AHMED, A. Ahmed, Abdeta Muktar Ahmed, Afrah Ahmed, Ahmed A, Ahmed, A., Ahmed, Aijaz, Aijaz Ahmed

553

Publications

18.1K

Citations

H-Index

202

Concepts

All Affiliations

Stanford University Stanford Medicine Inova Fairfax Hospital Baylor College of Medicine Alameda Health System

About

Aijaz Ahmed is an author at Stanford University specializing in medicine, hepatology, and epidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	37	81	6.2K
2	Public Health	21	31	1.4K
3	Health Sciences	16	18	1.8K
4	Education	1	1	11
5	Language Studies	1	1	33

Aijaz Ahmed

166

Publications

11.2K

Citations

H-Index

Page 1

	Year	Citations
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial Zobair M. Younossi, Vlad Ratziu, Rohit Loomba, The Lancet Interim AnalysisMetabolic Associated SteatohepatitisHepatologyPlacebo-controlled Phase 3Nonalcoholic Fatty Liver Disease	2019	1.2K
Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates Zobair M. Younossi, Maria Stepanova, Janus P. Ong, Clinical Gastroenterology and Hepatology	2018	795
Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S. Robert J. Wong, Ramsey Cheung, Aijaz Ahmed Hepatology	2013	713
Nonalcoholic Steatohepatitis Is the Most Rapidly Increasing Indication for Liver Transplantation in the United States Zobair M. Younossi, Maria Stepanova, Janus P. Ong, Clinical Gastroenterology and Hepatology HepatologyNonalcoholic Fatty Liver DiseaseSolid Organ TransplantationLiver PhysiologyPathology	2020	535
Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States Donghee Kim, Peter Konyn, Keeryth K. Sandhu, Journal of Hepatology Metabolic DisorderFatty Liver DiseaseUnited StatesObesityMetabolic Syndrome	2021	404
Alcoholic Liver Disease Replaces Hepatitis C Virus Infection as the Leading Indication for Liver Transplantation in the United States George Cholankeril, Aijaz Ahmed Clinical Gastroenterology and Hepatology Leading IndicationHepatologyHepatitis CViral HepatitisLiver Physiology	2017	260
Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes George Cholankeril, Robert J. Wong, Menghan Hu, Digestive Diseases and Sciences Transplantation SurgeryHepatologyTemporal TrendsSolid Organ TransplantationNonalcoholic Steatohepatitis	2017	231
High Prevalence of Concurrent Gastrointestinal Manifestations in Patients With Severe Acute Respiratory Syndrome Coronavirus 2: Early Experience From California George Cholankeril, Alexander Podboy, Vasiliki I. Aivaliotis, Gastroenterology Concurrent Gastrointestinal ManifestationsVirus EpidemiologyViral DiagnosticsRespiratory DiseasesEarly Experience	2020	218
Ultra‐Deep Pyrosequencing of Hepatitis B Virus Quasispecies from Nucleoside and Nucleotide Reverse‐Transcriptase Inhibitor (NRTI)–Treated Patients and NRTI‐Naive Patients Severine Margeridon‐Thermet, Nancy S. Shulman, Aijaz Ahmed, The Journal of Infectious Diseases Genetic EpidemiologyHepatitis BPathologyMolecular BiologyNrti‐naive Patients	2009	208
Changing Trends in Etiology‐Based and Ethnicity‐Based Annual Mortality Rates of Cirrhosis and Hepatocellular Carcinoma in the United States Donghee Kim, Andrew A. Li, Brandon J. Perumpail, Hepatology Hcc-related Mortality RatesHealth DisparitiesMortality RatesUnited StatesLogistic Analysis	2018	196

Page 1